| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 428 |
| 1 | PREDNISONE | 162 |
| 2 | ASPIRIN | 147 |
| 3 | METHOTREXATE SODIUM | 146 |
| 4 | ASPIRIN 325 MG | 145 |
| 5 | ASPIRIN 81 MG | 145 |
| 6 | METHOTREXATE | 134 |
| 7 | RISANKIZUMAB-RZAA | 118 |
| 8 | INFLIXIMAB | 113 |
| 9 | PANTOPRAZOLE | 97 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IODINE 2% | 1 | 0.1000 |
| 1 | ACELLULAR TISSUE ENGINEERED VESSEL | 1 | 0.0909 |
| 2 | OLMESARTAN MEDOXOMIL AMLODIPINE AND HYDROCHLOROTHIAZIDE | 1 | 0.0588 |
| 3 | L-PHENYLALANINE | 1 | 0.0127 |
| 4 | INFLIXIMAB-DYYB | 32 | 0.0093 |
| 5 | LIDOCAINE HCL AND MENTHOL | 1 | 0.0074 |
| 6 | AMISULPRIDE | 30 | 0.0049 |
| 7 | LEVOKETOCONAZOLE | 3 | 0.0040 |
| 8 | PSYLLIUM HUSK | 5 | 0.0037 |
| 9 | ESOMEPRAZOLE SODIUM | 8 | 0.0033 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 276 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 272 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 226 |
| 3 | Interleukin-23 Antagonist [EPC] | 201 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 148 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 134 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 103 |
| 7 | Integrin Receptor Antagonist [EPC] | 99 |
| 8 | Janus Kinase Inhibitor [EPC] | 97 |
| 9 | Purine Antimetabolite [EPC] | 97 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasopressin Receptor Agonist [EPC] | 4 | 0.0121 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 9 | 0.0043 |
| 2 | Cortisol Synthesis Inhibitor [EPC] | 3 | 0.0040 |
| 3 | Dopamine-2 Receptor Antagonist [EPC] | 30 | 0.0038 |
| 4 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 5 | Provitamin D2 Compound [EPC] | 74 | 0.0025 |
| 6 | Interleukin-23 Antagonist [EPC] | 201 | 0.0019 |
| 7 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 8 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 1 | 0.0013 |
| 9 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 4 | 0.0012 |